
Advanced Renal Cell Carcinoma: Patient Communication and Expectations in First-Line Therapy
Clinicians weigh tolerability against slight tumor growth, using patient-shared scan review and calling for AI volumetric imaging to avoid premature therapy switches.
Episodes in this series

In this segment, the discussion focuses on how clinicians communicate prognosis and treatment expectations to patients with advanced renal cell carcinoma, particularly in the context of first-line therapy. Dr. Brian Rini emphasizes that while long-term remission and even the possibility of cure can occur in select patients, the primary focus should remain on delivering the most effective initial treatment rather than planning for subsequent lines of therapy. He highlights that discussions around future treatments are often kept general, reassuring patients that additional options exist without overemphasizing sequencing. The conversation also underscores the importance of not prematurely discontinuing effective therapy, as early imaging changes may not always represent true progression. Dr. Rini stresses the value of reviewing imaging directly with patients to provide context and reduce anxiety associated with radiology reports. This segment reinforces the importance of clear, balanced communication and clinical judgment in managing advanced renal cell carcinoma.


































































